227 related articles for article (PubMed ID: 25448122)
1. [From COPD definitions to COPD phenotypes].
Burgel PR
Presse Med; 2014 Dec; 43(12 Pt 1):1337-43. PubMed ID: 25448122
[TBL] [Abstract][Full Text] [Related]
2. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and functional assessment in COPD: from case finding to follow-up].
Degano B; Soumagne T
Presse Med; 2014 Dec; 43(12 Pt 1):1344-52. PubMed ID: 25455633
[TBL] [Abstract][Full Text] [Related]
4. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary function tests in chronic obstructive pulmonary disease].
Weitzenblum E; Canuet M; Kessler R; Chaouat A
Presse Med; 2009 Mar; 38(3):421-31. PubMed ID: 19171454
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
Barczyk A; Pierzchała W
Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
[TBL] [Abstract][Full Text] [Related]
8. Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.
Postma DS; Anzueto AR; Jenkins C; Make BJ; Similowski T; Östlund O; Eriksson GS; Calverley PM
Respir Med; 2013 Dec; 107(12):1939-47. PubMed ID: 23953956
[TBL] [Abstract][Full Text] [Related]
9. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
[TBL] [Abstract][Full Text] [Related]
10. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and management of chronic obstructive pulmonary disease].
Sato N; Kanazawa M
Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
[TBL] [Abstract][Full Text] [Related]
12. An integrated approach to the medical treatment of chronic obstructive pulmonary disease.
Rosenberg SR; Kalhan R
Med Clin North Am; 2012 Jul; 96(4):811-26. PubMed ID: 22793946
[TBL] [Abstract][Full Text] [Related]
13. Global assessment of the COPD patient: time to look beyond FEV1?
Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
[TBL] [Abstract][Full Text] [Related]
14. The impact of heart failure on the classification of COPD severity.
Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in smokers: focus on functional limitations rather than on lung function?
Geijer RM; Sachs AP; Verheij TJ; Kerstjens HA; Kuyvenhoven MM; Hoes AW
Br J Gen Pract; 2007 Jun; 57(539):477-82. PubMed ID: 17550673
[TBL] [Abstract][Full Text] [Related]
16. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
Zuwallack RL; Nici L
COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
[TBL] [Abstract][Full Text] [Related]
17. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
18. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
19. Optimizing chronic obstructive pulmonary disease management in primary care.
Yawn BP
South Med J; 2011 Feb; 104(2):121-7. PubMed ID: 21079536
[TBL] [Abstract][Full Text] [Related]
20. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
Mroz RM; Minarowski L; Chyczewska E
Adv Exp Med Biol; 2013; 756():23-8. PubMed ID: 22836615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
